Mainland Chinese drug effective in treating 3 cancer types: Hong Kong-led study

Mainland Chinese drug effective in treating 3 cancer types: Hong Kong-led study

CUHK researchers say drug D3S-001 can treat non-small cell lung, colorectal and pancreatic cancers triggered by gene mutation KRAS-G12C.

A new drug against three types of cancer with limited therapeutic options has shown "promising" results in a multinational study led by the Chinese University of Hong Kong (CUHK), which evaluated its efficacy in patients with tumors associated with the genetic mutation KRAS-G12C. CUHK researchers reported Monday through their website that the drug has shown encouraging progress in their phase one clinical trial against non-small cell lung cancer…

Cetuximab β/FOLFIRI Prolongs Survival vs FOLFIRI in RAS/BRAF Wild-Type mCRC

For patients with right-sided CRC tumors, no significant progression-free survival difference was observed between the cetuximab and FOLFIRI-only groups.